seems not great, but still a pretty impressive year at likely 2,900 boe/day average, us$52m revenue.
what I'm not as clear on is the impact of "More fracture stimulation fluid...being recovered by [the three recent] wells than from...previous wells" and the reduced production from surrounding wells.
Obviously the fact that the chairman is still buying up shares /acting as a backstop is positive. Would be even better to see other insiders stumping up with decent sized purchases